CAROZZI, VALENTINA ALDA
 Distribuzione geografica
Continente #
NA - Nord America 10.371
EU - Europa 5.704
AS - Asia 3.026
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 21
SA - Sud America 18
AF - Africa 11
Totale 19.181
Nazione #
US - Stati Uniti d'America 10.161
CN - Cina 1.346
IT - Italia 1.055
DE - Germania 1.034
SE - Svezia 888
SG - Singapore 874
IE - Irlanda 818
UA - Ucraina 589
RU - Federazione Russa 515
GB - Regno Unito 298
HK - Hong Kong 297
CA - Canada 205
VN - Vietnam 174
FI - Finlandia 148
AT - Austria 109
FR - Francia 75
IN - India 74
DK - Danimarca 65
JP - Giappone 61
ID - Indonesia 52
TR - Turchia 46
KR - Corea 41
BE - Belgio 33
NL - Olanda 30
MY - Malesia 22
EU - Europa 19
IR - Iran 17
AU - Australia 16
NZ - Nuova Zelanda 14
BR - Brasile 11
PL - Polonia 10
EG - Egitto 7
ES - Italia 6
MX - Messico 5
PH - Filippine 5
RS - Serbia 5
TW - Taiwan 5
AE - Emirati Arabi Uniti 4
CH - Svizzera 4
HR - Croazia 4
HU - Ungheria 4
CL - Cile 3
NO - Norvegia 3
RO - Romania 3
A1 - Anonimo 2
CO - Colombia 2
LB - Libano 2
MD - Moldavia 2
NG - Nigeria 2
SA - Arabia Saudita 2
SC - Seychelles 2
AL - Albania 1
BG - Bulgaria 1
CZ - Repubblica Ceca 1
EE - Estonia 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
LV - Lettonia 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
VE - Venezuela 1
Totale 19.181
Città #
Ann Arbor 2.213
Woodbridge 900
Dublin 792
Chandler 741
Singapore 704
Houston 653
Jacksonville 619
Frankfurt am Main 606
Fairfield 534
Dearborn 505
Wilmington 485
Milan 411
Ashburn 398
Hangzhou 332
New York 321
Princeton 304
Hong Kong 277
Seattle 219
Nanjing 199
Cambridge 165
Santa Clara 158
Boardman 144
Shanghai 132
Vienna 108
Beijing 103
Lachine 102
Altamura 92
Dong Ket 89
Lawrence 82
Guangzhou 73
Nanchang 72
Shenyang 60
Jakarta 52
Andover 51
Toronto 45
Grafing 37
Helsinki 35
Jiaxing 35
Ottawa 34
Fremont 33
San Diego 33
Changsha 32
Hebei 31
Jinan 31
Carate Brianza 30
Tianjin 30
Falls Church 28
Nürnberg 28
Rome 28
Brussels 27
Chicago 27
Los Angeles 27
Pune 26
Kunming 24
Zhengzhou 24
London 23
Mountain View 22
Ningbo 20
Shangdi 20
Dallas 19
Melzo 19
Codroipo 17
Tokyo 17
Bergamo 16
Norwalk 16
Phoenix 16
Leawood 14
Taizhou 14
Edmonton 13
Hefei 13
Pasir Mas 12
Shinjuku 12
Washington 12
Huizen 11
Kiev 11
Lissone 11
San Mateo 11
Florence 10
Paris 10
Sesto San Giovanni 10
Sacramento 9
Bologna 8
Changchun 8
Fuzhou 8
Auburn Hills 7
Haikou 7
Lappeenranta 7
Philadelphia 7
Redmond 7
Romola 7
Seoul 7
Ankara 6
Detroit 6
Elmhurst 6
Frederick 6
Monza 6
Piemonte 6
Suwon 6
Trieste 6
University Park 6
Totale 13.846
Nome #
Multimodal assessment of painful peripheral neuropathy induced by chronic oxaliplatin-based chemotherapy in mice 412
Therapeutic potential of Mesenchymal Stem Cells for the treatment of diabetic peripheral neuropathy 292
Age-related changes in the function and structure of the peripheral sensory pathway in mice 292
High-dose intravenous immunoglobulins reduce nerve macrophage infiltration and the severity of bortezomib-induced peripheral neurotoxicity in rats 292
Global transcriptomic profile of dorsal root ganglion and physiological correlates of cisplatin-induced peripheral neuropathy 287
Peripheral neuropathy induced by microtubule-targeted chemotherapies: Insights into acute injury and long-term recovery 286
Susceptibility of different mouse strains to oxaliplatin peripheral neurotoxicity: Phenotypic and genotypic insights 273
Anti-tumor efficacy assessment of the sigma receptor pan modulator RC-106. A promising therapeutic tool for pancreatic cancer 239
Chemotherapy-induced peripheral neurotoxicity in immune-deficient mice: New useful ready-to-use animal models 233
Neuropathic pain is reduced in acid sphingomyelinase deficient mice. 231
Role of Organic Transporters 1 and 2 in Cisplatin mediated neurotoxicity 230
Neurofilament light chain: a specific serum biomarker of axonal damage severity in rat models of Chemotherapy-Induced Peripheral Neurotoxicity 212
Calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity 202
Molsidomine reduces the severity of Vincristine-induced peripheral neurotoxicity in rats 199
Bortezomib-induced painful peripheral neuropathy: an electrophysiological, behavioral, morphological and mechanistic study in the mouse 192
Neurofilament light chain as disease biomarker in a rodent model of chemotherapy induced peripheral neuropathy 181
Bortezomib-induced painful neuropathy in rats: a behavioral, neurophysiological and pathological study in rats 180
Neutrophil depletion affects Dark Agouti Experimental Autoimmune Encephalomyelitis 180
The relevance of multimodal assessment in experimental oxaliplatin-induced peripheral neurotoxicity 178
Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model 177
CR4056, a new analgesic I2 ligand, is highly effective against bortezomib-induced painful neuropathy in rats 175
Therapeutic Administration of Mesenchymal Stem Cells Abrogates the Relapse Phase in Chronic Relapsing-Remitting EAE 170
The ventral caudal nerve: a physiologic-morphometric study in three different rat strains 169
Blood molecular biomarkers for chemotherapy-induced peripheral neuropathy: From preclinical models to clinical practice 168
Molsidomide provides neuroprotection against vincristine-induced peripheral neurotoxicity 165
Islet transplantation and insulin administration relieve long-term complications and rescue the residual endogenous pancreatic β cells 164
Expression, distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 164
In vivo comparative study of the cytotoxicity of a liposomal formulation of cisplatin (lipoplatin™) 163
Paclitaxel: Chemotherapy and Neurotoxicity – The Two sides of the Coin 161
Platinum-taxane combination chemotherapy: General and peripheral neurotoxicity of their combined administration in the rat 160
Platinum-Taxane combination chemotherapy: assessment of electrophysiologic pathologic and morphometric fetures in chronic wistar rat models 157
Effect of the chronic combined administration of cisplatin and paclitaxel in a rat model of peripheral neurotoxicity 156
Neurophysiological and neuropathological characterization of new murine models of chemotherapy-induced chronic peripheral neuropathies 155
Lipoplatin tm: a less neurotoxic formulation of cisplatin 155
Continuous Buprenorphine Delivery Effect in Streptozotocine-Induced Painful Diabetic Neuropathy in Rats 153
Cr4056: a novel potent anti-nociceptive agent for several animal models of neuropathic pain 153
Bortezomib-Induced Peripheral Neurotoxicity: a Preclinical Model to Study Neuropathic Pain in Rat 153
Platinum-taxane combination chemotherapy: Description of the first study to assess the general and peripheral neurotoxicity of their combined administration in the rat 151
Focus on the role of Glutamate in the pathology of the peripheral nervous system 148
EVALUATION OF THE EFFICACY OF PERIPHAGEN NEUROTROPHIN-3 EXPRESSING VECTOR FOR OXALIPLATIN INDUCED PERIPHERAL NEUROPATHY. 148
Animal Models for the Study of Human Central and Peripheral Nervous System Diseases 147
Reply to a comment paper on the published paper by canta, a. Et al: “calmangafodipir reduces sensory alterations and prevents intraepidermal nerve fibers loss in a mouse model of oxaliplatin induced peripheral neurotoxicity”—antioxidants 2020, 9, 594 147
Givinostat-Liposomes: Anti-Tumor Effect on 2D and 3D Glioblastoma Models and Pharmacokinetics 147
Transplanted pancreatic islets survive and reverse type I diabetic neuropathy 145
Valproate protective effects on cisplatin-induced peripheral neuropathy: An in vitro and in vivo study 144
Lack of sterol regulatory element binding factor-1c imposes glial fatty acid utilization leading to peripheral neuropathy 144
Docetaxel-induced peripheral neuropathy: Protective effects of dihydroprogesterone and progesterone in an experimental model 142
Pathogenesis of platinum-induced peripheral neurotoxicity: Insights from preclinical studies 141
The Role of Oxidative Stress and Anti-Oxidant Treatment in Platinum-Induced Peripheral Neurotoxicity 138
Antibody Against Tumor Necrosis Factor-α Reduces Bortezomib-induced Allodynia in a Rat Model 138
The role of the complete Freund’s adjuvant and neutrophils in actively induced Lewis rat EAE 136
Intravenous Immunoglobulin Preparation Attenuates Pain Behaviors in a Wistar Rat Model of Bortezomib-Induced Peripheral Neuropathy 135
Regression of diabetic complications by islet transplantation in the rat 133
Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice 132
The role of glutamate in diabetic and in chemotherapy induced peripheral neuropathies and its regulation by glutamate carboxypeptidase II. 132
Preventive treatment with anti-rat neutrophil serum affects the relapsing phase in Dark Agouti EAE rats 132
Long-term recovery from chemotherapy-induced neuropathy following paclitaxel, ixabepilone, eribulin and vinorelbine in mice 130
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system 129
Ethoxyquin is effective in preventing cisplatin-induced painful peripheral neuropathy in rats 128
A Possible role of OCT2 gene in the development of peripheral neurotoxicity induced by cisplatin 128
Multimodal experimental approach to the study of human neurological diseases 126
Neutrophil depletion during sensitization phase affects the chronic phase of Experimental Autoimmune Encephalomyelitis 125
Ethoxyquin provides neuroprotection against cisplatin-induced neurotoxicity 125
Effect of preventive and therapeutic treatment of ghrelin agonist HM01 on the peripheral neurotoxicity induced by bortezomib in wistar rats. 125
Characterization of bortezomib-induced peripheral neuropathy in an immune-suppressed murine model 124
ERIBULIN, PACLITAXEL, IXABEPILONE AND VINORELBINE-INDUCED PERIPHERAL NEUROPATHY IN MICE: INSIGHTS IN LONG-TERM RECOVERY 124
Oxaliplatin induces pH acidification in dorsal root ganglia neurons 124
Comparison of neuropathy-inducing effects of eribulin mesylate, paclitaxel, and ixabepilone in mice 123
MSCs effect on Dark Agouti rats affected by chronic EAE 123
ANALGELSIC EFFECT OF BUPRENORPHINE IN AN EXPERIMENTAL MODEL OF PAINFUL DIABETIC PERIPHERAL NEUROPATHY 123
Imunohystochemical characterization of the distribution of glutamate receptors, “high affinity” membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia. 123
The severity of oxaliplatin neurotoxicity is related to differential expression of a solute transporter in mice 123
Human Immunoglobulins ameliorate pain in rats with bortezomib-induced peripheral neuropathy 123
Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy 122
BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY: STUDY OF PROTEASOME INHIBITION AND MICROTUBULE STABILIZATION MECHANISMS IN RAT MODEL 122
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms? 122
Ivig Effect In A Wistar Rat Model Of Bortezomib-Induced Peripheral Neuropathy 122
Bortezomib-induced neuropathic pain: evaluation of antinociceptive effect of a new analgesic compound 121
Evaluation of tubulin polymerization and chronic inhibition of proteasome as citotoxicity mechanisms in bortezomib-induced peripheral neuropathy 120
Bortezomib treatment produces nocifensive behavior and changes in the expression of TRPV1, CGRP, and substance P in the rat DRG, spinal cord, and sciatic nerve 120
Oxaliplatin Neurotoxicity is related to SLC4A1 Expression in BALB/c Mice Dorsal Root Ganglia 119
Correlation between organic cation transporter expression in rat dorsal root ganglia neurons and cisplatin-induced peripheral neurotoxicity 118
electrophysiological, behavioural and morphological characterization of oxaliplatin-induced painful peripheral neuropathy in mice 118
Morpho-Functional Characterisation of the Rat Ventral Caudal Nerve in a Model of Axonal Peripheral Neuropathy 117
Effect of proteasome inhibition on the central and peripheral nervous system 117
CISPLATIN, EPOTHILONE B AND BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHIES: A NEUROPHYSIOLOGICAL STUDY IN THE MOUSE. 115
Co-trasplantation of Pancreatic Islets with Mesenchymal Stem Cells promotes the functional recovery of diabetic neuropathy in vivo 115
Blood neurofilament light chains as a potential damage marker in chemotherapy-induce peripheral neuropathy rodent models 114
Expression, distribution and glutamate uptake activity of excitatory aminoacid transporters in in vitro cultures of embryonic rat dorsal root ganglia 113
Characterization of Glutamate Transporters in Peripheral Nervous System. 112
Glutamate Carboxypeptidase II inhibition in several rat models of chemotherapy-induced peripheral neurotoxicity 112
Oxaliplatin-Induced Peripheral Neurotoxicity: Morphological Characterization In Different Mouse Strains 112
Characterization of the neurotoxicity and antineoplastic activity of bortezomib in a new myeloma-bearing murine model. 111
Organic cation transporters and cisplatin-induced peripheral neurotoxicity in dorsal root ganglia neurons 110
Functional recovery with syngeneically transplanted microcapsulated pancreatic islets in streptozotocin-induced diabetic rats. 109
Glutamate carboxypeptidase inhibition reduces the severity of chemotherapy-induced peripheral neurotoxicity in rat 108
Glutamate Carboxypeptidase II (GCPII, NAALADASE) inhibition protects against Cisplatin-induced peripheral neurotoxicity in a rat model. 106
Effects of palmitoylethanolamide (pea) in cisplatin-induced peripheral neuropathy in mice. 105
Calcium-related neurotoxicity of oxaliplatin: Understanding the mechanisms to drive therapy 102
EXPRESSION OF TRPV1 AND CGRP IN SPINAL PRIMARY AFFERENT NEURONS IN A RAT MODEL OF BORTEZOMIB-INDUCED PERIPHERAL NEUROPATHY TREATED WITH ANALGESICS 101
Totale 15.398
Categoria #
all - tutte 65.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.407 0 0 0 182 301 389 525 217 284 252 217 40
2020/20212.636 139 113 297 295 208 184 278 204 242 222 162 292
2021/20221.700 102 165 121 158 144 195 68 91 70 127 113 346
2022/20233.212 383 842 338 278 213 518 56 164 280 34 65 41
2023/20242.685 97 77 104 115 326 670 465 128 172 67 49 415
2024/20251.914 399 851 610 54 0 0 0 0 0 0 0 0
Totale 20.277